Endothelial dysfunction is associated with activation of the type I interferon system and platelets in patients with systemic lupus erythematosus
H Tydén, C Lood, B Gullstrand, CT Nielsen… - RMD open, 2017 - rmdopen.bmj.com
H Tydén, C Lood, B Gullstrand, CT Nielsen, NHH Heegaard, R Kahn, A Jönsen…
RMD open, 2017•rmdopen.bmj.comObjectives Endothelial dysfunction may be connected to cardiovascular disease (CVD) in
systemic lupus erythematosus (SLE). Type I interferons (IFNs) are central in SLE
pathogenesis and are suggested to induce both endothelial dysfunction and platelet
activation. In this study, we investigated the interplay between endothelial dysfunction,
platelets and type I IFN in SLE. Methods We enrolled 148 patients with SLE and 79 sex-
matched and age-matched healthy controls (HCs). Type I IFN activity was assessed with a …
systemic lupus erythematosus (SLE). Type I interferons (IFNs) are central in SLE
pathogenesis and are suggested to induce both endothelial dysfunction and platelet
activation. In this study, we investigated the interplay between endothelial dysfunction,
platelets and type I IFN in SLE. Methods We enrolled 148 patients with SLE and 79 sex-
matched and age-matched healthy controls (HCs). Type I IFN activity was assessed with a …
Objectives
Endothelial dysfunction may be connected to cardiovascular disease (CVD) in systemic lupus erythematosus (SLE). Type I interferons (IFNs) are central in SLE pathogenesis and are suggested to induce both endothelial dysfunction and platelet activation. In this study, we investigated the interplay between endothelial dysfunction, platelets and type I IFN in SLE.
Methods
We enrolled 148 patients with SLE and 79 sex-matched and age-matched healthy controls (HCs). Type I IFN activity was assessed with a reporter cell assay and platelet activation by flow cytometry. Endothelial dysfunction was assessed using surrogate markers of endothelial activation, soluble vascular cell adhesion molecule-1 (sVCAM-1) and endothelial microparticles (EMPs), and finger plethysmograph to determine Reactive Hyperaemia Index (RHI).
Results
In patients with SLE, type I IFN activity was associated with endothelial activation, measured by high sVCAM-1 (OR 1.68, p<0.01) and elevated EMPs (OR 1.40, p=0.03). Patients with SLE with high type I IFN activity had lower RHI than HCs (OR 2.61, p=0.04), indicating endothelial dysfunction.
Deposition of complement factors on platelets, a measure of platelet activation, was seen in patients with endothelial dysfunction. High levels of sVCAM-1 were associated with increased deposition of C4d (OR 4.57, p<0.01) and C1q (OR 4.10, p=0.04) on platelets. High levels of EMPs were associated with C4d deposition on platelets (OR 3.64, p=0.03).
Conclusions
Endothelial dysfunction was associated with activation of platelets and the type I IFN system. We suggest that an interplay between the type I IFN system, injured endothelium and activated platelets may contribute to development of CVD in SLE.
rmdopen.bmj.com